NovAliX has achieved substantial revenue from its collaborations with biopharma customers and drug-discovery partners, predominantly in Europe, and is now expanding in the United States and Japan.
Organizations Involved
Max Planck Institute
Founders
Stephan Jenn
Company Description
NovAliX is a company that aids managers, scientists, and project managers with drug discovery projects.